These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9198619)

  • 1. [Early discovery of hepatocellular carcinoma].
    Tanikawa K
    Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):402-5. PubMed ID: 9198619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].
    Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological markers of hepatocellular carcinoma].
    Deugnier Y; Auffret P; Lehry D; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):648-57. PubMed ID: 2826282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Kubota T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].
    Yamashiki M; Kosaka Y
    Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 8. Glypican-3 immunostaining significantly improves histological diagnosis of hepatocellular carcinoma.
    Honsová E; Lodererová A; Franková S; Oliverius M; Trunecka P
    Cas Lek Cesk; 2011; 150(1):37-40. PubMed ID: 21400962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genomic analysis of hepatocellular carcinoma and its application to diagnosis].
    Murakami Y
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():458-61. PubMed ID: 20979296
    [No Abstract]   [Full Text] [Related]  

  • 11. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 15. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract]   [Full Text] [Related]  

  • 16. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of PIVKA-II in patients with hepatocellular carcinoma. Detection of PIVKA-II by EIA using anti-PIVKA-II monoclonal antibody].
    Ohtani M; Ido K; Kawamoto C; Kimura K
    Rinsho Byori; 1989 Apr; 37(4):405-9. PubMed ID: 2545953
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of histological biopsy diagnosis of hepatocellular carcinoma by genomic biomarkers?
    Lamerz R
    Gut; 2011 Jul; 60(7):881-2. PubMed ID: 21436226
    [No Abstract]   [Full Text] [Related]  

  • 19. [High risk group for development of hepatocellular carcinoma].
    Koike Y; Shiratori Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker].
    Yamano M
    Nihon Rinsho; 1990 Feb; 48 Suppl():999-1002. PubMed ID: 1693989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.